# Brian Keil

> Brian Keil is a seed investor at Alumni Ventures backing Artificial Intelligence. See 61 investments, check sizes, portfolio and contact details. Updated Oct…

- Type: Angel Investor
- Fund: [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group)
- Location: New York, United States
- Total investments: 61
- Last investment: Feb 2026
- Lead investor: 11%
- Last updated: Oct 2026
- LinkedIn: http://www.linkedin.com/pub/brian-keil/0/22/4a
- X (Twitter): http://twitter.com/bpkeil
- Facebook: http://www.facebook.com/bpkeil

Brian Keil is a seed investor at Alumni Ventures in New York focused on Artificial Intelligence and Software. Brian Keil: Brian is a Managing Director and Founding Member of the Peacock Equity Fund, a joint initiative sponsored by GE Commercial Finance and NBC Universal. He Prior to joining the Peacock Fund, Brian was a Senior Vice President at GE Equity for 8 years where he led a number of transactions in the enterprise software, business services, andmedia sectors. Brian received a B.S. in Industrial Engineering from the University of Southern California and an M.B.A. from the Wharton School.

## Contacts

5 contacts available for Brian Keil: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/brian-keil?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 20 | 33% |
| Software | 14 | 23% |
| Health Care | 7 | 11% |
| Information Technology | 7 | 11% |
| Semiconductor | 5 | 8% |

95 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 18 | 30% |
| Series A | 11 | 18% |
| Series B | 11 | 18% |
| Venture - Series Unknown | 5 | 8% |
| Series C | 4 | 7% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 41 | 67% |
| Australia | 3 | 5% |
| United Kingdom | 2 | 3% |
| Israel | 1 | 2% |
| Singapore | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NODA AI | NODA AI builds defense focused algorithm using software for collaborative autonomous systems. | $25M | Series A | Feb 26, 2026 | https://www.nodaintelligence.ai/ |
| Neurophos | Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference by replacing traditional electronic compute elements with optical processing units (OPUs). The company’s technology uses ultra-dense optical modulators and silicon photonics to enable computation using light,aiming to support matrix operations central to AI workloads with increased energy efficiency and performance relative to conventional graphics processing units. Neurophos’ offerings include prototype OPUs and development systems designed to integrate into data center environments, and its platform targets engineering teams and compute-intensive applications that demand scalable AI inference capability. The business collaborates with industry partners and investors to advance its optical compute architecture and develop supporting software stacks and hardware modules for deployment. Neurophos also engages in pilot programs and partnerships to test its photonic processors in real-world compute environments and explore integration pathways with existing infrastructure. Its work leverages research in metamaterials and compute-in-memory design to reduce power consumption and enhance throughput for AI inference tasks. | $110M | Series A | Jan 22, 2026 | https://www.neurophos.com/ |
| Haiqu | Haiqu Inc. is a quantum computing software firm focusing on the development of enabling technology to improve the performance of modern quantum hardware. Their software addresses the adoption obstacles that prevent scalable quantum applications from being realized, allowing for a broader variety of practical use cases in finance, life sciences,mobility, and other fields. | $11M | Seed | Jan 13, 2026 | https://www.haiqu.ai |
| Iambic | The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant, a multi-modal transformer model that predicts clinical outcomes from the earliest stages of discovery, and NeuralPLexer, the best-in-class predictor of protein and protein-ligand structures.The integration of physics principles into the platform’s AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multi-parameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated experimental execution, Iambic completes design-make-test cycles on a weekly cadence. | $127.8M |  | Nov 10, 2025 | https://www.entos.ai/ |
| Heidi Health | Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows. | $65M | Series B | Oct 06, 2025 | https://www.heidihealth.com.au |
| F2 AI | F2 AI offers an AI platform specifically designed for private markets, including private finance, private equity, and commercial banking. | $10M | Seed | Sep 16, 2025 | https://www.f2.ai/ |
| Observe | Observe is an observability platform built on a streaming data lake for faster search and correlation at a lower cost. The company uses an O11y Knowledge Graph to structure logs, metrics, and traces as entities with semantic relationships. It also uses O11y AI to help resolve incidents faster and reduce costs. | $156M | Series C | Jul 30, 2025 | https://www.observeinc.com/ |
| Teramount | Teramount changes the world of silicon photonics by offering a novel solution, the patent-pending Photonic-Plug, for connecting optics to silicon.Teramount Photonic-Plug enables standard semiconductor manufacturing processes and packaging flow in silicon photonics, thus enables any fabless semiconductor company to expand into silicon photonicswhile working with traditional foundries and OSATs. | $50M | Series A | Jul 29, 2025 | http://www.teramount.com/#teramount |
| Avalanche | Avalanche is a decentralized platform designed for building scalable applications and custom blockchain networks. |  | Series A | Jul 11, 2025 | https://www.avalanchefusion.com |
| Pano | Pano offers hardware and software technology solutions for fire professionals to detect threats. Pano provides tools to the government, utilities, insurers, and private landowners in order to mitigate wildfire threats and protect lives, property, and the environment. Pano is a unified enterprise solution that combines cutting-edge hardware,artificial intelligence, and software. | $44M | Series B | Jun 16, 2025 | https://www.pano.ai/ |

10 of 61 investments shown.

## Co-investors
- [Red & Blue Ventures](https://shizune.co/investors/profile/red-blue-ventures) — VC Fund, 5 deals together
- [Silicon Catalyst](https://shizune.co/investors/profile/silicon-catalyst) — VC Fund, 5 deals together
- [Capital One Ventures](https://shizune.co/investors/profile/capital-one-ventures) — VC Fund, 4 deals together
- [MaC Venture Capital](https://shizune.co/investors/profile/mac-venture-capital) — VC Fund, 4 deals together
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund, 3 deals together
- [Construct Capital](https://shizune.co/investors/profile/construct-capital) — VC Fund, 3 deals together

## About Alumni Ventures

VC Fund · Manchester, United States

Alumni Ventures identifies and co-invests in deals alongside various established venture capital firms across multiple stages, from pre-seed to later-stage growth. Investors can participate through annual funds containing multiple companies or via a syndicate for individual deal-by-deal selections. The firm maintains several distinct investmentteams that evaluate opportunities across sectors such as artificial intelligence, healthcare, and strategic technology.

5 contacts available at Alumni Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Aaron Sandford | Graphic Designer | https://shizune.co/investors/profile/aaron-sandford |
| Alea Capello | 'People and Culture, Associate | https://shizune.co/investors/profile/alea-capello-alea-capello-64e1 |
| Alexandra Critch | Product Manager Lead MarTec | https://shizune.co/investors/profile/alexandra-critch |
| Alex Ovabor | VenturesCorps Analyst | https://shizune.co/investors/profile/alex-ovabor |
| Allison Newman | Paralegal, Compliance Officer | https://shizune.co/investors/profile/allison-newman |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Brian Keil invest in?

Brian Keil invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 61 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Brian Keil?

Public channels for Brian Keil include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Brian Keil last invest?

The most recent investment recorded for Brian Keil closed in Feb 2026. Shizune tracks 61 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co